Crossver SRL
The score of Crossver shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +28 % Total assets +22 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Crossver's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jul 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 11 Jul 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Crossver's financial analysis
- Solvency30.2%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Crossver
Crossver's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0838.471.265
- VAT number
- BE0838471265
- Peppol
- Registered · 0208:0838471265 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Jul 2011
- Registered office
- 8710 Wielsbeke
- Latest accounts
- 2025 · filed on 08 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Crossver (SRL) has been based in Wielsbeke since 2011, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 2,841 € and equity of €1.14m; its revenue is not published. Its solvency stands at 30.2%, below the median of its sector (44.0%).
Companies similar to Crossver
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apotheek Devriese Retail sale of pharmaceutical products Torhout · balance sheet €3.84m
- Pharmaceutica Retail sale of pharmaceutical products Lier · balance sheet €3.84m
- Unifarma Retail sale of pharmaceutical products Kortrijk · balance sheet €3.56m
- E.V.N. Pharma Retail sale of pharmaceutical products Grimbergen · balance sheet €3.28m
- Mouscron Pharma Retail sale of pharmaceutical products Mouscron · balance sheet €3.25m
- GDK Farma Retail sale of pharmaceutical products Grimbergen · balance sheet €3.07m
- Xpharma Retail sale of pharmaceutical products Puurs-Sint-Amands · balance sheet €3.07m
Frequently asked questions about Crossver
What is the revenue of Crossver?
Crossver files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Crossver?
In Belgium, the VAT number is the company number prefixed with BE: BE0838471265 for Crossver, if the company is VAT-registered. Its company number (CBE) is 0838.471.265.
Where is the registered office of Crossver?
According to the CBE register, the registered office of Crossver is in 8710 Wielsbeke.
What is the equity of Crossver?
At the close of the 2025 financial year, the equity of Crossver amounts to 1,142,937 €, a solvency of 30.2% of total assets.
Who manages Crossver?
The register lists 1 active mandates at Crossver. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Crossver
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →